Medical tourism consulting for US-based cancer diagnostics and treatment
盛诺一家operates a medical tourism advisory service focused on cancer care assessment for Chinese patients traveling to the US. The tech stack reveals a dual-track operation: heavy use of short-video platforms (Douyin, Kuaishou, Xiaohongshu) for patient acquisition and marketing, paired with a modern AI/LLM backbone (LangChain, LlamaIndex, RAG, Milvus, Pinecone, Claude, GPT, DeepSeek, Qwen) for clinical decision support and content generation. The presence of prompt-engineering projects and vector-database infrastructure suggests they're building internal AI tooling for medical expertise synthesis — a strategic move to scale oncology consultation beyond their current expert network bottleneck, which appears in their stated pain points.
Notable leadership hires: Mechanical Department Head, Tax Director, Video Content Lead
盛诺一家is a medical tourism and consultation firm based in Beijing, serving Chinese patients seeking diagnostic and treatment services in the United States, with a primary focus on oncology assessment. The company operates across three main functions: patient acquisition and engagement (via social video platforms), clinical advisory and case management (oncology experts), and operational coordination of overseas treatment processes. With 27 employees distributed across sales, marketing, healthcare, and engineering teams, the organization is structured to handle patient intake, expert consultation coordination, and content-driven marketing. The business model combines high-touch expert consultation with scalable digital marketing and emerging AI-assisted triage infrastructure.
盛诺一家 is a medical tourism consulting firm that helps Chinese patients navigate diagnostic assessment and treatment planning in the United States, specializing in cancer care. They combine expert oncology consultation with operational support for overseas patient journeys.
The company uses LangChain, LlamaIndex, RAG, Milvus, and Pinecone for AI-powered content and clinical decision support, alongside LLMs including Claude, GPT, DeepSeek, and Qwen. These enable automated expertise synthesis and prompt-based case analysis.
Primary channels are short-video platforms (Douyin, Kuaishou, Xiaohongshu) for patient engagement and awareness, supplemented by traditional marketing via YouTube and Instagram. The company is actively pursuing expansion of B2B referral channels to diversify acquisition.